The U.S. Food and Drug Administration has approved NEREUS (tradipitant), developed by Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), for preventing vomiting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE